Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study.
The clinical management of pancreatic cancer is severely hampered by the absence of effective screening tools.Sixty-seven biomarkers were evaluated in prediagnostic sera obtained from cases of pancreatic cancer enrolled in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).The...
Main Authors: | Brian M Nolen, Randall E Brand, Denise Prosser, Liudmila Velikokhatnaya, Peter J Allen, Herbert J Zeh, William E Grizzle, Ying Huang, Aleksey Lomakin, Anna E Lokshin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3991628?pdf=render |
Similar Items
-
Prediagnostic Serum Biomarkers as Early Detection Tools for Pancreatic Cancer in a Large Prospective Cohort Study
by: Nolen, Brian M., et al.
Published: (2014) -
An extensive targeted proteomic analysis of disease-related protein biomarkers in urine from healthy donors.
by: Brian M Nolen, et al.
Published: (2013-01-01) -
Correction: prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study.
Published: (2015-01-01) -
Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma.
by: Judith Schwartzbaum, et al.
Published: (2015-01-01) -
A nested case-control study of 277 prediagnostic serum cytokines and glioma.
by: Judith Schwartzbaum, et al.
Published: (2017-01-01)